Mechanisms underlying the inhibitory effects of arsenic compounds on protein tyrosine phosphatase (PTP).

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Toxicology and Applied Pharmacology

• Publication date

  2012-09-15

• Fields of study

  Medicine, Chemistry, Environmental Science

• Identifiers
  DOI 10.1016/j.taap.2012.06.019PMID 22771847
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The endoplasmic reticulum is a target organelle for trivalent dimethylarsinic acid (DMAIII)-induced cytotoxicity.

  2012cited by this paper
• Arsenic metabolism and thioarsenicals.

  2012cited by this paper
• Mitochondria are the main target organelle for trivalent monomethylarsonous acid (MMA(III))-induced cytotoxicity.

  2011cited by this paper
• Potent inhibition of protein tyrosine phosphatase 1B by copper complexes: implications for copper toxicity in biological systems.

  2010cited by this paper
• The two faces of PTP1B in cancer.

  2010cited by this paper
• A Novel Nanoparticulate Formulation of Arsenic Trioxide with Enhanced Therapeutic Efficacy in a Murine Model of Breast Cancer

  2010cited by this paper
• Identification of the major arsenic-binding protein in rat plasma as the ternary dimethylarsinous-hemoglobin-haptoglobin complex.

  2008cited by this paper
• Identification of reactive cysteines in a protein using arsenic labeling and collision-induced dissociation tandem mass spectrometry.

  2008cited by this paper
• Study of interactions between arsenicals and thioredoxins (human and E. coli) using mass spectrometry.

  2007cited by this paper
• Chemical Knockdown of Protein-tyrosine Phosphatase 1B by 1,2-Naphthoquinone through Covalent Modification Causes Persistent Transactivation of Epidermal Growth Factor Receptor*

  2007cited by this paper
• Kinetics and mechanism of protein tyrosine phosphatase 1B inactivation by acrolein.

  2007cited by this paper
• Targeting thioredoxin reductase is a basis for cancer therapy by arsenic trioxide

  2007cited by this paper
• Cys-Oxidation of Protein Tyrosine Phosphatases: Its Role in Regulation of Signal Transduction and Its Involvement in Human Cancers

  2006cited by this paper
• Arsenic trioxide: new clinical experience with an old medication in hematologic malignancies.

  2005cited by this paper
• Protein Tyrosine Phosphatases as Targets of the Combined Insulinomimetic Effects of Zinc and Oxidants

  2005cited by this paper
• Evidence of hemoglobin binding to arsenic as a basis for the accumulation of arsenic in rat blood.

  2004cited by this paper
• Interaction of trivalent arsenicals with metallothionein.

  2003cited by this paper
• Chemical and mechanistic approaches to the study of protein tyrosine phosphatases.

  2003cited by this paper
• Metal and redox modulation of cysteine protein function.

  2003cited by this paper
• The paradox of arsenic: molecular mechanisms of cell transformation and chemotherapeutic effects.

  2002cited by this paper
• Activation of Rac1 and the p38 Mitogen-activated Protein Kinase Pathway in Response to Arsenic Trioxide*

  2002cited by this paper
• Protein tyrosine phosphatases: structure and function, substrate specificity, and inhibitor development.

  2002cited by this paper
• Monomethylarsonous acid (MMA(III)) and arsenite: LD(50) in hamsters and in vitro inhibition of pyruvate dehydrogenase.

  2001cited by this paper
• Structural and Evolutionary Relationships among Protein Tyrosine Phosphatase Domains

  2001cited by this paper
• Regulation of receptor tyrosine kinase signaling by protein tyrosine phosphatases.

  2001cited by this paper
• Arsenic in drinking water.

  2001cited by this paper
• Signaling—2000 and Beyond

  2000cited by this paper
• Form, function, and regulation of protein tyrosine phosphatases and their involvement in human diseases.

  2000cited by this paper
• Methylarsenicals and arsinothiols are potent inhibitors of mouse liver thioredoxin reductase.

  1999cited by this paper
• Reversible Inactivation of Protein-tyrosine Phosphatase 1B in A431 Cells Stimulated with Epidermal Growth Factor*

  1998cited by this paper
• Binding of arsenicals to proteins in an in vitro methylation system.

  1997cited by this paper
• Protein tyrosine phosphatases in signal transduction.

  1997cited by this paper
• Comparative inhibition of yeast glutathione reductase by arsenicals and arsenothiols.

  1997cited by this paper
• Protein tyrosine phosphatases take off

  1995cited by this paper
• Signal transduction by receptors with tyrosine kinase activity.

  1990cited by this paper

• Differential metabolism of arsenicals regulates Fps1-mediated arsenite transport

  2022cites this paper
• An arsenic stress signaling code in yeast

  2021cites this paper
• Arsenic disrupts neuronal insulin signaling through increasing free PI3K-p85 and decreasing PI3K activity.

  2021cites this paper
• Arsenic and other metals as phenotype driving electrophiles in carcinogenesis.

  2021cites this paper
• Methylated metabolite of arsenite blocks glycerol production in yeast by inhibition of glycerol-3-phosphate dehydrogenase

  2019cites this paper
• Non-redox cycling mechanisms of oxidative stress induced by PM metals.

  2019cites this paper
• Environmental Arsenic Exposure and Human Health Risk

  2019cites this paper
• Using mathematical modeling to infer the valence state of arsenicals in tissues: A PBPK model for dimethylarsinic acid (DMAV) and dimethylarsinous acid (DMAIII) in mice.

  2019cites this paper
• Multidrug Resistance Protein 1 (MRP1/ABCC1)-Mediated Cellular Protection and Transport of Methylated Arsenic Metabolites Differs between Human Cell Lines

  2018cites this paper
• Stressing out or stressing in: intracellular pathways for SAPK activation

  2018cites this paper
• Intracellular mechanism by which arsenite activates the yeast stress MAPK Hog1

  2018cites this paper
• Metabolism, toxicity and anticancer activities of arsenic compounds

  2017cites this paper
• Blocking two-component signalling enhances Candida albicans virulence and reveals adaptive mechanisms that counteract sustained SAPK activation

  2017cites this paper
• The interactions of metal cations and oxyanions with protein tyrosine phosphatase 1B

  2017cites this paper
• Cellular arsenic transport pathways in mammals.

  2016cites this paper
• Embryo Microinjection of Selenomethionine Reduces Hatchability and Modifies Oxidant Responsive Gene Expression in Zebrafish

  2016cites this paper
• Synergistic augmentation of ATP-induced interleukin-6 production by arsenite in HaCaT cells

  2016cites this paper
• Arsenic Triglutathione [As(GS)3] Transport by Multidrug Resistance Protein 1 (MRP1/ABCC1) Is Selectively Modified by Phosphorylation of Tyr920/Ser921 and Glycosylation of Asn19/Asn23

  2016cites this paper
• The Chemistry and Metabolism of Arsenic

  2015cites this paper
• Importance of being thiomethylated: formation, fate, and effects of methylated thioarsenicals.

  2015cites this paper
• Mechanisms of Arsenic Toxicity in Humans: Interplay of Arsenic, Glutathione, and DNA Methylation in Bangladeshi Adults

  2014cites this paper
• Trivalent methylated arsenic metabolites induce apoptosis in human myeloid leukemic HL-60 cells through generation of reactive oxygen species.

  2014cites this paper
• Acute and long-term effects of arsenite in HepG2 cells: modulation of insulin signaling

  2014cites this paper
• Effects of dietary and in ovo selenomethionine exposure in zebrafish

  2014cites this paper
• Goto-Kakizaki rats: its suitability as non-obese diabetic animal model for spontaneous type 2 diabetes mellitus.

  2013cites this paper
• The DNT-EST: a predictive embryonic stem cell-based assay for developmental neurotoxicity testing in vitro.

  2013cites this paper
• Novel Targets for Metal Compounds Inducing Carcinogenesis

  2013cites this paper
• Evaluation of the carcinogenicity of inorganic arsenic

  2013cites this paper
• Arsenic Binding to Proteins

  2013cites this paper
• Double-edged effects of arsenic compounds: anticancer and carcinogenic effects.

  2013cites this paper
• Arsenite-induced stress signaling: Modulation of the phosphoinositide 3′-kinase/Akt/FoxO signaling cascade☆

  2013cites this paper